Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 What is the role of melatonin in the management of sleep disorders in children?

Literature DB >> 19030321

What is the role of melatonin in the management of sleep disorders in children?

Nina Buscemi¹, Manisha Witmans.

Abstract

Entities: Chemical Disease Species

Year: 2006 PMID： 19030321 PMCID： PMC2528645 DOI： 10.1093/pch/11.8.517

Source DB: PubMed Journal: Paediatr Child Health ISSN： 1205-7088 Impact factor: 2.253

× No keyword cloud information.

14 in total

Review 1. Melatonin therapy for circadian rhythm sleep disorders in children with multiple disabilities: what have we learned in the last decade?

Authors: James E Jan; Roger D Freeman
Journal: Dev Med Child Neurol Date: 2004-11 Impact factor: 5.449

2. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.

Authors: S H Downs; N Black
Journal: J Epidemiol Community Health Date: 1998-06 Impact factor: 3.710

3. Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Authors: A R Jadad; R A Moore; D Carroll; C Jenkinson; D J Reynolds; D J Gavaghan; H J McQuay
Journal: Control Clin Trials Date: 1996-02

4. Add-on melatonin improves sleep behavior in children with epilepsy: randomized, double-blind, placebo-controlled trial.

Authors: Madhur Gupta; Satinder Aneja; Kamlesh Kohli
Journal: J Child Neurol Date: 2005-02 Impact factor: 1.987

5. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

Authors: K F Schulz; I Chalmers; R J Hayes; D G Altman
Journal: JAMA Date: 1995-02-01 Impact factor: 56.272

6. Use of melatonin to treat sleep disorders in tuberous sclerosis.

Authors: F J O'Callaghan; A A Clarke; E Hancock; A Hunt; J P Osborne
Journal: Dev Med Child Neurol Date: 1999-02 Impact factor: 5.449

7. Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians.

Authors: Judith A Owens; Carol L Rosen; Jodi A Mindell
Journal: Pediatrics Date: 2003-05 Impact factor: 7.124

8. Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial.

Authors: Giangennaro Coppola; Giusi Iervolino; Marina Mastrosimone; Graziella La Torre; Francesca Ruiu; Antonio Pascotto
Journal: Brain Dev Date: 2004-09 Impact factor: 1.961

9. The use of pharmacotherapy in the treatment of pediatric insomnia in primary care: rational approaches. A consensus meeting summary.

Authors: Judith A Owens; Deborah Babcock; Jeffrey Blumer; Ronald Chervin; Richard Ferber; Mark Goetting; Daniel Glaze; Anna Ivanenko; Jodi Mindell; Marsha Rappley; Carol Rosen; Stephen Sheldon
Journal: J Clin Sleep Med Date: 2005-01-15 Impact factor: 4.062

What is the role of melatonin in the management of sleep disorders in children?

Review 1. Melatonin therapy for circadian rhythm sleep disorders in children with multiple disabilities: what have we learned in the last decade?

2. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.

3. Assessing the quality of reports of randomized clinical trials: is blinding necessary?

4. Add-on melatonin improves sleep behavior in children with epilepsy: randomized, double-blind, placebo-controlled trial.

5. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

6. Use of melatonin to treat sleep disorders in tuberous sclerosis.

7. Medication use in the treatment of pediatric insomnia: results of a survey of community-based pediatricians.

8. Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial.

9. The use of pharmacotherapy in the treatment of pediatric insomnia in primary care: rational approaches. A consensus meeting summary.

10. The treatment of sleep disorders with melatonin.

1. Shedding light on the effectiveness of melatonin for circadian rhythm sleep disorders.

2. STATEMENT ON PEDIATRIC TRAVELLERS: Committee to Advise on Tropical Medicine and Travel.

3. Stress: Neurobiology, consequences and management.

4. Primary care hypnotic and anxiolytic prescription: Reviewing prescribing practice over 8 years.